GN Store Nord ASGGNDF 73 Days Payable is 106.24 as of Mar. 2026, which is 49% above its 10-year median of 71.08. GuruFocus rates GGNDF with a GF Score™ of 73/100 and a GF Value™ of $15.78 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, GN Store Nord AS ranks better than 51.45% on this metric.
The historical rank and industry rank for GN Store Nord AS's Days Payable or its related term are showing as below:
GGNDF'
s Days Payable Range Over the Past 10 Years
Min: 54.13 Med: 71.08 Max: 98.27
Current: 70.72
During the past 13 years, GN Store Nord AS's highest Days Payable was 98.27. The lowest was 54.13. And the median was 71.08.
GGNDF's Days Payable is ranked better than 51.45% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs GGNDF: 70.72
GN Store Nord AS's Days Payable
declined
from Mar. 2025 (123.62) to Mar. 2026 (106.24).
It may suggest that GN Store Nord ASaccelerated paying its suppliers.
GN Store Nord AS Days Payable Related Terms
GN Store Nord AS Days Payable Historical Data
* Premium members only.
The historical data trend for GN Store Nord AS's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, GN Store Nord AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GN Store Nord AS Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GN Store Nord AS's Days Payable distribution charts can be found below:
* The bar in red indicates where GN Store Nord AS's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
GN Store Nord AS's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GN Store Nord AS (GGNDF) has a Days Payable of 106.24 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GN Store Nord AS and its competitors. This is 49% above median its historical median of 71.08. Over the past decade, GN Store Nord AS's Days Payable has ranged from 54.13 to 98.27. According to the industry distribution chart, GN Store Nord AS ranks #386 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 48.6%.
Is GN Store Nord AS's Days Payable too high?
GN Store Nord AS's current Days Payable of 106.24 is 49% above median its 10-year median of 71.08. Over the past 10 years, this metric has ranged from a low of 54.13 to a high of 98.27. The Medical Devices & Instruments industry median Days Payable is 67.87. GN Store Nord AS's value of 106.24 is 56.5% above this industry median. Based on the distribution chart, GN Store Nord AS ranks #386 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, GN Store Nord AS has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GN Store Nord AS's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, GN Store Nord AS ranks #386 out of 795 companies for Days Payable. This puts GN Store Nord AS in the upper half of its industry. The industry median Days Payable is 67.87. GN Store Nord AS's value of 106.24 is 56.5% above this benchmark. Historically, GN Store Nord AS's own Days Payable has ranged from 54.13 to 98.27 over the past decade. While the company's 10-year median is 71.08 vs. the industry median of 67.87, GN Store Nord AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GN Store Nord AS's current Days Payable of 106.24 is 56.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GN Store Nord AS and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GN Store Nord AS's current Days Payable is 106.24, which is 49% above median its own 10-year median of 71.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GN Store Nord AS stock overvalued right now?
Based on GuruFocus' analysis, GN Store Nord AS (GGNDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $15.78, compared to a current price of $13.63 — trading 13.7% below its estimated fair value. The current Days Payable is 106.24, which is 49% above median its 10-year median of 71.08 and 56.5% above the Medical Devices & Instruments industry median of 67.87. GN Store Nord AS's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For GN Store Nord AS (GGNDF), the current Days Payable is 106.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GN Store Nord AS (GGNDF) Overvalued in 2026?
Based on GuruFocus' analysis, GN Store Nord AS stock appears to be undervalued.
The current stock price of $13.63 is trading 13.7% below its estimated GF Value™ of $15.78.
GuruFocus considers GN Store Nord AS to be Modestly Undervalued.
Key valuation signals for GGNDF:
Days Payable: 106.24 (49% above median its 10-year median of 71.08)
GF Value™: $15.78 vs. price of $13.63 (13.7% below fair value)
Industry Position: 56.5% above the Medical Devices & Instruments median (#386 of 795)
No single metric tells the full story. See the GGNDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GN Store Nord is a Danish company offering medical and audio solutions. The group comprises three businesses: hearing (about 40% of sales), enterprise (40%), and gaming (20%). GN Hearing offers hearing aids and competes globally with Sonova, Demant, Starkey, and WS Audiology (formerly Sivantos and Widex). GN Enterprise provides headsets and speakerphones to the enterprise market, including contact centers and offices. GN recently acquired SteelSeries, a provider of gaming accessories such as headsets and keyboards, thereby forming the gaming division. The company has positioned itself as a major player in the Unified Communication-enabled headsets market. The firm's premium brands are Resound in hearing, Jabra in headsets, and SteelSeries in gaming.
73GF Score
Get the complete analysis for GGNDF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GGNDF has been successfully added to your 
